These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1910815)

  • 1. Chondroitin sulfate in sputum from patients with cystic fibrosis and chronic bronchitis.
    Rahmoune H; Lamblin G; Lafitte JJ; Galabert C; Filliat M; Roussel P
    Am J Respir Cell Mol Biol; 1991 Oct; 5(4):315-20. PubMed ID: 1910815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chondroitinase ABC on purulent sputum from cystic fibrosis and other patients.
    Khatri IA; Bhaskar KR; Lamont JT; Sajjan SU; Ho CK; Forstner J
    Pediatr Res; 2003 Apr; 53(4):619-27. PubMed ID: 12612214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sialylation of bronchial mucins secreted by patients suffering from cystic fibrosis or from chronic bronchitis is related to the severity of airway infection.
    Davril M; Degroote S; Humbert P; Galabert C; Dumur V; Lafitte JJ; Lamblin G; Roussel P
    Glycobiology; 1999 Mar; 9(3):311-21. PubMed ID: 10024669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum.
    Lethem MI; James SL; Marriott C
    Am Rev Respir Dis; 1990 Nov; 142(5):1053-8. PubMed ID: 2240828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of bronchial mucins isolated from the sputum of patients suffering from cystic fibrosis or other chronic bronchial diseases (author's transl)].
    Lamblin G; Lhermitte M; Lafitte JJ; Filliat M; Degand P; Roussel P
    Bull Eur Physiopathol Respir; 1977; 13(1):175-90. PubMed ID: 843646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid analysis of sputum from patients with chronic bronchial diseases.
    Galabert C; Filliat M; Lamblin G
    Bull Eur Physiopathol Respir; 1981; 17(2):197-208. PubMed ID: 7284646
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased iron and ferritin content of sputum from patients with cystic fibrosis or chronic bronchitis.
    Stites SW; Walters B; O'Brien-Ladner AR; Bailey K; Wesselius LJ
    Chest; 1998 Sep; 114(3):814-9. PubMed ID: 9743172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble proteins of bronchopulmonary secretions from patients with cystic fibrosis, asthma, and bronchitis.
    Brogan TD; Ryley HC; Neale L; Yassa J
    Thorax; 1975 Feb; 30(1):72-9. PubMed ID: 47656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory reaction and airway damage in cystic fibrosis.
    Barton AD; Ryder K; Lourenço RV; Dralle W; Weiss SG
    J Lab Clin Med; 1976 Sep; 88(3):423-6. PubMed ID: 8575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.
    Henke MO; Renner A; Huber RM; Seeds MC; Rubin BK
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):86-91. PubMed ID: 14988081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical markers of mucous and serum glycoproteins and their relation to viscosity in mucoid and purulent sputum from various hypersecretory diseases.
    Lopez-Vidriero MT; Reid L
    Am Rev Respir Dis; 1978 Mar; 117(3):465-77. PubMed ID: 629481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracheobronchial surface active material in cystic fibrosis.
    Griese M; Duroux A; Schams A; Lenz AG; Kleinsasser N
    Eur J Med Res; 1997 Mar; 2(3):114-20. PubMed ID: 9113501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex pattern of the myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation.
    Roth J; Teigelkamp S; Wilke M; Grün L; Tümmler B; Sorg C
    Immunobiology; 1992 Nov; 186(3-4):304-14. PubMed ID: 1490735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sputum leukotrienes in obstructive airways diseases.
    O'Driscoll BR; Cromwell O; Kay AB
    Clin Exp Immunol; 1984 Feb; 55(2):397-404. PubMed ID: 6321071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the in vivo degradation of human respiratory mucins during Pseudomonas aeruginosa infection.
    Houdret N; Ramphal R; Scharfman A; Perini JM; Filliat M; Lamblin G; Roussel P
    Biochim Biophys Acta; 1989 Jul; 992(1):96-105. PubMed ID: 2752044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding of amikacin to macromolecules from the sputum of patients suffering from respiratory diseases.
    Bataillon V; Lhermitte M; Lafitte JJ; Pommery J; Roussel P
    J Antimicrob Chemother; 1992 May; 29(5):499-508. PubMed ID: 1624390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ceruloplasmin, haptoglobin and transferrin levels in bronchial secretions of children with chronic respiratory tract diseases].
    Gaweł J; Herman T; Zebrak J
    Probl Med Wieku Rozwoj; 1984; 13():84-90. PubMed ID: 6531357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anomalous structure of urinary chondroitin sulfate from cancer patients. A potential new marker for diagnosis of neoplasias.
    Dietrich CP; Martins JR; Sampaio LO; Nader HB
    Lab Invest; 1993 Apr; 68(4):439-45. PubMed ID: 8479152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in adhesion of Pseudomonas aeruginosa to mucin glycopeptides from sputa of patients with cystic fibrosis and chronic bronchitis.
    Ramphal R; Houdret N; Koo L; Lamblin G; Roussel P
    Infect Immun; 1989 Oct; 57(10):3066-71. PubMed ID: 2777373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of proteoglycan production by intrahepatic biliary epithelial cells bearing defective (delta-f508) cystic fibrosis transmembrane conductance regulator.
    Bhaskar KR; Turner BS; Grubman SA; Jefferson DM; LaMont JT
    Hepatology; 1998 Jan; 27(1):7-14. PubMed ID: 9425910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.